A Phase 2 Trial of Radium(223) and Stereotactic Ablative Radiotherapy in Hormone-Naive Men with Oligometastatic Prostate Cancer to Bone: The RadSABR study. Tward J, Lloyd S, Johnson S, Dechet C, et al. Int J Radiat Oncol Biol Phys 2025 Feb 6:S0360-3016(25)00095.

Read + Share

Amedeo Smart

Independent Medical Education